Trademark: 79259194
Status Date
Tuesday, April 28, 2020
Registration Number
6039264
Registration Date
Tuesday, April 28, 2020
Filing Date
Tuesday, December 18, 2018
Published for Opposition
Tuesday, February 11, 2020
5 Diagnostic and prognostic reagents and preparations for medical purposes; diagnostic and prognostic reagents and preparations for laboratory testing for medical purposes, including laboratory testing of samples from patients
44 Medical services, including diagnostic and prognostic services, guiding treatment options; RNA and DNA analysis, namely, genetic testing for medical purposes; medical analysis services for the diagnosis, prognosis and treatment of persons provided by medical laboratories
10 Diagnostic and prognostic apparatuses, devices and instruments for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic apparatuses, devices and instruments for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis
42 Computer-aided diagnostic and prognostic testing services, including analyzing samples from patients to provide diagnosis and prognosis and guiding treatment options, namely, medical laboratory services; software as a service (Saas) services featuring software for diagnosis and prognosis of immune-related diseases; software as a service (SaaS) services featuring software for providing diagnostic or prognostic results and guiding treatment options based on data from patient samples; design and development of diagnostic and prognostic apparatus, devices, kits and instruments; medical and scientific research, design and development of diagnostic and prognostic tests, including diagnostic and prognostic tests relating to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis
Feb 12, 2024
New Representative At Ib Received
Sep 26, 2020
Final Decision Transaction Processed By Ib
Sep 6, 2020
Final Disposition Notice Sent To Ib
Aug 31, 2020
Final Disposition Processed
Jul 28, 2020
Final Disposition Notice Created, To Be Sent To Ib
Apr 28, 2020
Registered-Principal Register
Feb 14, 2020
Notification Processed By Ib
Feb 11, 2020
Official Gazette Publication Confirmation E-Mailed
Feb 11, 2020
Published For Opposition
Jan 29, 2020
Notification Of Possible Opposition Sent To Ib
Jan 29, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 22, 2020
Notification Of Notice Of Publication E-Mailed
Jan 2, 2020
Approved For Pub - Principal Register
Dec 19, 2019
Teas/Email Correspondence Entered
Dec 18, 2019
Correspondence Received In Law Office
Dec 18, 2019
Teas Response To Office Action Received
Dec 17, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 17, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 12, 2019
Refusal Processed By Ib
Jun 22, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jun 22, 2019
Refusal Processed By Mpu
Jun 4, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jun 3, 2019
Non-Final Action Written
Jun 1, 2019
Application Filing Receipt Mailed
May 28, 2019
Assigned To Examiner
May 28, 2019
New Application Office Supplied Data Entered
May 23, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
